SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies gets marketing approval from 4 countries for chemotherapy drugs

05 Jul 2023 Evaluate

Venus Remedies has received marketing approval from Oman, Malaysia, Bosnia and Trinidad and Tobago for key chemotherapy drugs. With this, it has secured 503 marketing approvals for its oncology products across 75 countries. 

These marketing approvals will enable it to expand its operations to new geographies and open up new avenues for advanced cancer treatment with improved outcomes for patients battling various types of cancer.

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers. 

Venus Remedies Share Price

1019.70 -22.65 (-2.17%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×